litlas
ログインアカウント作成

Richard M. Stone

1970–2026 年に発表

別表記
Richard M Stone
317
論文数
66,772
被引用数
132
h 指数
307
i10 指数

被引用数

Richard M. Stone の年別被引用数1975 年: 被引用 2 件1978 年: 被引用 1 件1982 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 5 件1986 年: 被引用 7 件1988 年: 被引用 4 件1989 年: 被引用 5 件1990 年: 被引用 6 件1991 年: 被引用 14 件1992 年: 被引用 16 件1993 年: 被引用 14 件1994 年: 被引用 18 件1995 年: 被引用 16 件1996 年: 被引用 22 件1997 年: 被引用 23 件1998 年: 被引用 35 件1999 年: 被引用 38 件2000 年: 被引用 53 件2001 年: 被引用 40 件2002 年: 被引用 67 件2003 年: 被引用 119 件2004 年: 被引用 132 件2005 年: 被引用 168 件2006 年: 被引用 204 件2007 年: 被引用 289 件2008 年: 被引用 329 件2009 年: 被引用 392 件2010 年: 被引用 376 件2011 年: 被引用 335 件2012 年: 被引用 410 件2013 年: 被引用 401 件2014 年: 被引用 389 件2015 年: 被引用 419 件2016 年: 被引用 470 件2017 年: 被引用 520 件2018 年: 被引用 511 件2019 年: 被引用 2,265 件2020 年: 被引用 2,603 件2021 年: 被引用 2,559 件2022 年: 被引用 2,058 件2023 年: 被引用 1,818 件2024 年: 被引用 2,917 件2025 年: 被引用 1,480 件2026 年: 被引用 28 件1976〜1977 年は被引用が無いため表示していません1979〜1981 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません1987 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 7,114 件、この内訳の 30.9%中国: 引用元論文 1,932 件、この内訳の 8.4%ドイツ: 引用元論文 1,695 件、この内訳の 7.3%イギリス: 引用元論文 1,313 件、この内訳の 5.7%イタリア: 引用元論文 1,282 件、この内訳の 5.6%フランス: 引用元論文 1,125 件、この内訳の 4.9%カナダ: 引用元論文 753 件、この内訳の 3.3%スペイン: 引用元論文 681 件、この内訳の 2.9%オーストラリア: 引用元論文 611 件、この内訳の 2.6%オランダ: 引用元論文 593 件、この内訳の 2.6%スイス: 引用元論文 525 件、この内訳の 2.3%日本: 引用元論文 484 件、この内訳の 2.1%
0%30.9%その他 21.4%

機関

分野

  • Medicine67.6%
  • Biochemistry, Genetics and Molecular Biology24.1%
  • Immunology and Microbiology4.8%
  • Computer Science0.7%
  • Materials Science0.6%
  • Chemistry0.4%
  • その他1.8%

トピック

  • Acute Myeloid Leukemia Research13.6%
  • Chronic Myeloid Leukemia Treatments5%
  • Acute Lymphoblastic Leukemia research4.2%
  • Myeloproliferative Neoplasms: Diagnosis and Treatment4.1%
  • Chronic Lymphocytic Leukemia Research3.3%
  • Hematopoietic Stem Cell Transplantation2.6%
  • その他67.2%

共著者

全論文

検索で開く
  1. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data

    著者: Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, Michael J. Borowitz, Katherine R. Calvo, Hans Michael Kvasnicka, Sa A. Wang, Adam Bagg, Tiziano Barbui, Susan Branford, Carlos E. Bueso‐Ramos, Jörge E. Cortes, Paola Dal Cin, Courtney D. DiNardo, Hervé Dombret, Eric J. Duncavage, Benjamin L. Ebert, Elihu H. Estey, Fabio Facchetti, Kathryn Foucar, Naseema Gangat, Umberto Gianelli, Lucy A. Godley, Nicola Gökbuget, Jason Gotlib, Eva Hellström‐Lindberg, Gabriela Hobbs, Ronald Hoffman, Elias Jabbour, Jean‐Jacques Kiladjian, Richard A. Larson, Michelle M. Le Beau, Mignon L. Loh, Bob Löwenberg, Elizabeth Macintyre, Luca Malcovati, Charles G. Mullighan, Charlotte M. Niemeyer, Olatoyosi Odenike, Seishi Ogawa, Alberto Órfão, Elli Papaemmanuil, Francesco Passamonti, Kimmo Porkka, Ching‐Hon Pui, Jerald P. Radich, Andreas Reiter, Marı́a Rozman, Martina Rudelius, Michael R. Savona, Charles A. Schiffer, Annette Schmitt‐Graeff, Akiko Shimamura, Jorge Sierra, Wendy Stock, Richard M. Stone, Martin S. Tallman, Jürgen Thiele, Hwei‐Fang Tien, Alexandar Tzankov, Alessandro M. Vannucchi, Paresh Vyas, Andrew H. Wei, Olga K. Weinberg, Agnieszka Wierzbowska, Mario Cazzola, Hartmut Döhner, Ayalew Tefferi - Blood 2022 被引用: 2,693

  2. Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity

    著者: Peter van Galen, Volker Hovestadt, Marc H. Wadsworth, Travis K. Hughes, Gabriel K. Griffin, Sofia Battaglia, Julia A. Verga, Jason Stephansky, Timothy J. Pastika, Jennifer Lombardi Story, Geraldine S. Pinkus, Olga Pozdnyakova, Ilene Galinsky, Richard M. Stone, Timothy A. Graubert, Alex K. Shalek, Jon C. Aster, Andrew A. Lane, B Bernstein - Cell 2019 被引用: 1,218

  3. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia

    著者: Ghayas C. Issa, Ibrahim Aldoss, John F. DiPersio, Branko Cuglievan, Richard M. Stone, Martha Arellano, Michael J. Thirman, Manish R. Patel, David S. Dickens, Shalini Shenoy, Neerav Shukla, Hagop M. Kantarjian, Scott A. Armstrong, Florian Perner, Jennifer A. Perry, Galit Rosen, Rebecca G. Bagley, Michael L. Meyers, Peter Ordentlich, Yu Gu, Vinit Kumar, Steven G. Smith, Gerard M. McGeehan, Eytan M. Stein - Nature 2023 被引用: 468

  4. Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    著者: Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford, Kristina Laumann, Susan M. Geyer, Clara D. Bloomfield, Christian Thiede, Thomas W. Prior, Konstanze Döhner, Guido Marcucci, Francesco Lo‐Coco, Rebecca B. Klisovic, Andrew H. Wei, Jorge Sierra, Miguel Á. Sanz, Joseph Brandwein, Théo de Witte, Dietger Niederwieser, Frederick R. Appelbaum, Bruno C. Medeiros, Martin S. Tallman, Jürgen Krauter, Richard F. Schlenk, Arnold Ganser, Hubert Serve, Gerhard Ehninger, Sergio Amadori, Richard A. Larson, Hartmut Döhner - New England Journal of Medicine 2017 被引用: 2,198

  5. Durable Remissions with Ivosidenib in IDH1 -Mutated Relapsed or Refractory AML

    著者: Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, Gail J. Roboz, Jessica K. Altman, Alice S. Mims, Ronan Swords, Robert H. Collins, Gabriel N. Mannis, Daniel A. Pollyea, Will Donnellan, Amir T. Fathi, Arnaud Pigneux, Harry P. Erba, Gabrielle T. Prince, Anthony S. Stein, Geoffrey L. Uy, James M. Foran, Elie Traer, Robert K. Stuart, Martha Arellano, James L. Slack, Mikkael A. Sekeres, Christophe Willekens, Sung Choe, Hongfang Wang, Vickie Zhang, Katharine Yen, Stephanie M. Kapsalis, Hua Yang, David L. Dai, Bin Fan, Meredith A. Goldwasser, Hua Liu, Sam Agresta, Bin Wu, Eyal C. Attar, Martin S. Tallman, Richard M. Stone, Hagop M. Kantarjian - New England Journal of Medicine 2018 被引用: 1,412

  6. Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

    著者: Lachelle D. Weeks, Abhishek Niroula, Donna Neuberg, Waihay J. Wong, R. Coleman Lindsley, Marlise R. Luskin, Nancy Berliner, Richard M. Stone, Daniel J. DeAngelo, Robert J. Soiffer, Md Mesbah Uddin, Gabriel K. Griffin, Caitlyn Vlasschaert, Christopher J. Gibson, Siddhartha Jaiswal, Alexander G. Bick, Luca Malcovati, Pradeep Natarajan, Benjamin L. Ebert - NEJM Evidence 2023 被引用: 295

  7. Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia

    著者: Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, Amir T. Fathi, Gail J. Roboz, Jessica K. Altman, Richard M. Stone, Daniel J. DeAngelo, Ross L. Levine, Ian W. Flinn, Hagop M. Kantarjian, Robert H. Collins, Manish R. Patel, Arthur E. Frankel, Anthony S. Stein, Mikkael A. Sekeres, Ronan Swords, Bruno C. Medeiros, Christophe Willekens, Paresh Vyas, Alessandra Tosolini, Qiang Xu, Robert Knight, Katharine Yen, Sam Agresta, Stéphane de Botton, Martin S. Tallman - Blood 2017 被引用: 1,469

  8. Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia

    著者: Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, Brenda Chyla, Leah J. Hogdal, Todd Busman, Evelyn McKeegan, Ahmed Hamed Salem, Ming Zhu, Justin L. Ricker, William Blum, Courtney D. DiNardo, Tapan M. Kadia, Martin Dunbar, Rachel Kirby, Nancy Falotico, Joel D. Leverson, Rod Humerickhouse, Mack Mabry, Richard M. Stone, Hagop M. Kantarjian, Anthony Letai - Cancer Discovery 2016 被引用: 1,056

  9. MEN1 mutations mediate clinical resistance to menin inhibition

    著者: Florian Perner, Eytan M. Stein, Daniela V. Wenge, Sukrit Singh, Jeonghyeon Kim, Athina Apazidis, Homa Rahnamoun, Disha Anand, Christian Marinaccio, Charlie Hatton, Yanhe Wen, Richard M. Stone, David Schaller, Shoron Mowla, Wenbin Xiao, Holly A. Gamlen, Aaron J. Stonestrom, Sonali Persaud, Elizabeth T. Ener, Jevon Cutler, John G. Doench, Gerard M. McGeehan, Andrea Volkamer, John D. Chodera, Radosław P. Nowak, Eric S. Fischer, Ross L. Levine, Scott A. Armstrong, Sheng F. Cai - Nature 2023 被引用: 243

  10. CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia

    著者: Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, Laura F. Newell, Tara L. Lin, Ellen K. Ritchie, Robert K. Stuart, Stephen A. Strickland, Donna E. Hogge, Scott R. Solomon, Richard M. Stone, Dale L. Bixby, Jonathan E. Kolitz, Gary J. Schiller, Matthew J. Wieduwilt, Daniel H. Ryan, Antje Hoering, Kamalika Banerjee, Michael Chiarella, Arthur C. Louie, Bruno C. Medeiros - Journal of Clinical Oncology 2018 被引用: 990

  11. Acute myeloid leukemia: 2023 update on diagnosis, risk‐stratification, and management

    著者: Shai Shimony, Maximilian Stahl, Richard M. Stone - American Journal of Hematology 2023 被引用: 438

  12. Acute myeloid leukemia ontogeny is defined by distinct somatic mutations

    著者: R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola, Peter Grauman, Sarah J. Shareef, Steven L. Allen, Arnaud Pigneux, Meir Wetzler, Robert K. Stuart, Harry P. Erba, Lloyd E. Damon, Bayard L. Powell, Neal I. Lindeman, David P. Steensma, Martha Wadleigh, Daniel J. DeAngelo, Donna Neuberg, Richard M. Stone, Benjamin L. Ebert - Blood 2014 被引用: 977

  13. Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms

    著者: Ofir Wolach, Rob S. Sellar, Kimberly Martinod, Deya Cherpokova, Marie McConkey, Ryan Chappell, Alexander J. Silver, Dylan Adams, Cecilia A. Castellano, Rebekka K. Schneider, Robert F. Padera, Daniel J. DeAngelo, Martha Wadleigh, David P. Steensma, Ilene Galinsky, Richard M. Stone, Giulio Genovese, Steven A. McCarroll, Bozenna Iliadou, Christina M. Hultman, Donna Neuberg, Ann Mullally, Denisa D. Wagner, Benjamin L. Ebert - Science Translational Medicine 2018 被引用: 454

  14. Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL

    著者: Jennifer A. Woyach, Amy S. Ruppert, Nyla A. Heerema, Weiqiang Zhao, Allison M. Booth, Wei Ding, Nancy L. Bartlett, Danielle M. Brander, Paul M. Barr, Kerry A. Rogers, Sameer A. Parikh, Steven Coutré, Arti Hurria, Jennifer R. Brown, Gerard Lozanski, James S. Blachly, Hatice Gülçin Özer, Brittny Major‐Elechi, Briant Fruth, Sreenivasa Nattam, Richard A. Larson, Harry P. Erba, Mark R. Litzow, Carolyn Owen, Charles Kuzma, Jeremy S. Abramson, Richard F. Little, Scott E. Smith, Richard M. Stone, Sumithra J. Mandrekar, John C. Byrd - New England Journal of Medicine 2018 被引用: 952

  15. Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma

    著者: Susanne H.C. Baumeister, Joana Murad, Lillian Werner, Heather Daley, Hélène Trebeden‐Negre, Joanina K. Gicobi, Adam Schmucker, Jake Reder, Charles L. Sentman, David E. Gilham, Frédéric Lehmann, Ilene Galinsky, Heidi DiPietro, Kristen Cummings, Nikhil C. Munshi, Richard M. Stone, Donna Neuberg, Robert J. Soiffer, Glenn Dranoff, Jerome Ritz, Sarah Nikiforow - Cancer Immunology Research 2018 被引用: 325

  16. Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia

    著者: Rongqing Pan, Leah J. Hogdal, Juliana M. Benito, Donna Bucci, Lina Han, Gautam Borthakur, Jörge E. Cortes, Daniel J. DeAngelo, LaKeisha Debose, Hong Mu, Hartmut Döhner, Verena I. Gaidzik, Ilene Galinsky, Leonard S. Golfman, Torsten Haferlach, Karine G. Harutyunyan, Jianhua Hu, Joel D. Leverson, Guido Marcucci, Markus Müschen, Rachel Newman, Eugene Park, Peter P. Ruvolo, Vivian Ruvolo, Jeremy Ryan, Sonja Schindela, Patrick A. Zweidler‐McKay, Richard M. Stone, Hagop M. Kantarjian, Michael Andreeff, Marina Konopleva, Anthony Letai - Cancer Discovery 2013 被引用: 735

  17. Ibrutinib–Rituximab or Chemoimmunotherapy for Chronic Lymphocytic Leukemia

    著者: Tait D. Shanafelt, Xin V. Wang, Neil E. Kay, Curtis A. Hanson, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong C. Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman - New England Journal of Medicine 2019 被引用: 738

  18. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    著者: Hervé Dombret, John F. Seymour, Aleksandra Butrym, Agnieszka Wierzbowska, Dominik Selleslag, Jun Ho Jang, Rajat Kumar, James D. Cavenagh, Andre C. Schuh, Anna Candoni, Christian Récher, Irwindeep Sandhu, Teresa Bernal del Castillo, Haifa Kathrin Al‐Ali, Giovanni Martinelli, José Falantes, Richard Noppeney, Richard M. Stone, Mark D. Minden, Heidi McIntyre, S. Songer, Lela M. Lucy, C. L. Beach, Hartmut Döhner - Blood 2015 被引用: 1,149

  19. Long-term outcomes for ibrutinib–rituximab and chemoimmunotherapy in CLL: updated results of the E1912 trial

    著者: Tait D. Shanafelt, Victoria Wang, Curtis A. Hanson, Elisabeth Paietta, Susan O’Brien, Jacqueline C. Barrientos, Diane F. Jelinek, Esteban Braggio, José F. Leis, Cong Christine Zhang, Steven Coutré, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Richard F. Little, Harry P. Erba, Richard M. Stone, Mark R. Litzow, Martin S. Tallman, Neil E. Kay - Blood 2022 被引用: 237

  20. An inflammatory state remodels the immune microenvironment and improves risk stratification in acute myeloid leukemia

    著者: Audrey Lasry, Bettina Nadorp, Maarten Fornerod, Deedra Nicolet, Huiyun Wu, Christopher J. Walker, Zhengxi Sun, Matthew T. Witkowski, Anastasia N. Tikhonova, Maria Guillamot-Ruano, Geraldine Cayanan, Anna Yeaton, Gabriel Robbins, Esther A. Obeng, Aristotelis Tsirigos, Richard M. Stone, John C. Byrd, Stanley Pounds, William L. Carroll, Tanja A. Grüber, Ann‐Kathrin Eisfeld, Iannis Aifantis - Nature Cancer 2022 被引用: 146

  21. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    著者: Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, Courtney D. DiNardo, Lucy A. Godley, Ilaria Iacobucci, Siddhartha Jaiswal, Luca Malcovati, Alessandro M. Vannucchi, Keyur P. Patel, Daniel A. Arber, Maria E. Arcila, Rafael Bejar, Nancy Berliner, Michael J. Borowitz, Susan Branford, Anna Brown, Catherine Cargo, Hartmut Döhner, Brunangelo Falini, Guillermo Garcia‐Manero, Torsten Haferlach, Eva Hellström‐Lindberg, Annette S. Kim, Jeffery M. Klco, Rami S. Komrokji, Mignon Lee-Cheun Loh, Sanam Loghavi, Charles G. Mullighan, Seishi Ogawa, Attilio Orazi, Elli Papaemmanuil, Andreas Reiter, David M. Ross, Michael R. Savona, Akiko Shimamura, Radek C. Skoda, Françesc Solé, Richard M. Stone, Ayalew Tefferi, Matthew J. Walter, David Wu, Benjamin L. Ebert, Mario Cazzola - Blood 2022 被引用: 208

  22. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

    著者: Brian Druker, François Guilhot, Stephen G. O’Brien, Insa Gathmann, Hagop M. Kantarjian, Norbert Gattermann, Michael W. Deininger, Richard T. Silver, John M. Goldman, Richard M. Stone, Francisco Cervantes, Andreas Hochhaus, Bayard L. Powell, Janice Gabrilove, Philippe Rousselot, Josy Reiffers, Jan J. Cornelissen, Timothy P. Hughes, Hermine Agis, Thomas Fischer, Gregor Verhoef, John D. Shepherd, Giuseppe Saglio, Aloïs Gratwohl, Johan Lanng Nielsen, Jerald P. Radich, Bengt Simonsson, Kerry Taylor, Michele Baccarani, Charlene So, Laurie Letvak, Richard A. Larson - New England Journal of Medicine 2006 被引用: 3,481

  23. Menin Inhibition With Revumenib for KMT2A -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)

    著者: Ghayas C. Issa, Ibrahim Aldoss, Michael J. Thirman, John F. DiPersio, Martha Arellano, James S. Blachly, Gabriel N. Mannis, Alexander E. Perl, David S. Dickens, Christine M. McMahon, Elie Traer, C. Michel Zwaan, Carolyn Grove, Richard M. Stone, Paul J. Shami, Ioannis Mantzaris, Matthew Greenwood, Neerav Shukla, Branko Cuglievan, Tibor Kovacsovics, Yu Gu, Rebecca G. Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole McNeer, Eytan M. Stein, Andrew H. Wei, Shaun Fleming, Himalee Sabins, Ibrahim Aldoss, Tibor Kovacsovics, Richard M. Stone, Martha Arellano, Manish R. Patel, Chetasi Talati, Jing Chen, Boaz Nachmias, Maël Heiblig, P Fernandez, Montserrat Arnan-Sangerman, Eytan M. Stein, Ioannis Mantzaris, James S. Blachly, Elie Traer, C. Michael Zwaan, Ofir Wolach, Giovanni Marconi, Ashish Bajel, Carolyn Grove, Gabriel N. Mannis, Andre C. Schuh, Michael J. Thirman, John Byrd, Christine M. McMahon, David S. Dickens, Alexander E. Perl, Matthew Greenwood, Ghayas C. Issa, James A. Whitlock, Paul J. Shami, John F. DiPersio - Journal of Clinical Oncology 2024 被引用: 184

  24. TET2-mutant clonal hematopoiesis and risk of gout

    著者: Mridul Agrawal, Abhishek Niroula, Pierre Cunin, Marie McConkey, Veronica Shkolnik, Peter G. Kim, Waihay J. Wong, Lachelle D. Weeks, Amy E. Lin, Peter G. Miller, Christopher J. Gibson, Aswin Sekar, Inga‐Marie Schaefer, Donna Neuberg, Richard M. Stone, Alexander G. Bick, Md Mesbah Uddin, Gabriel K. Griffin, Siddhartha Jaiswal, Pradeep Natarajan, Peter A. Nigrović, Deepak A. Rao, Benjamin L. Ebert - Blood 2022 被引用: 150